Skip navigation

Surfactant‐modified progesterone‐loaded PVP/cellulose fibres for future drug delivery applications in menopause

Surfactant‐modified progesterone‐loaded PVP/cellulose fibres for future drug delivery applications in menopause

Shafi, Omar, Swer, Michelle, Chan, Un Hou, Kassam, Alisha, Mirzarakhimov, Mirkomol, Huang, Jai Yi and Brako, F ORCID logoORCID: https://orcid.org/0000-0002-1163-1874 (2025) Surfactant‐modified progesterone‐loaded PVP/cellulose fibres for future drug delivery applications in menopause. Macromolecular Materials and Engineering, 310 (10). ISSN 1438-7492 (Print), 1439-2054 (Online) (doi:10.1002/mame.202500023)

[thumbnail of Open Access Article]
Preview
PDF (Open Access Article)
52677 BRAKO_Surfactant‐Modified_Progesterone‐Loaded_PVP_Cellulose_Fibres_(OA)_2025.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

Menopause often results in symptoms that impact physical and mental well‐being, and hormone replacement therapy (HRT) using progesterone (PGS) is a common treatment. This study explores PGS‐loaded transdermal cellulose‐based binary fibres as a potential adjunct for oestrogen in HRT. Using ethyl cellulose (EC) and cellulose acetate (CA) bound with Polyvinylpyrrolidone (PVP), the release of PGS is studied via a Franz Diffusion Cell system. Various analyses, including rheology, SEM, FTIR, in vitro drug release, and mathematical modelling, are conducted. SEM revealed that CA fibres are thinner than EC fibres, and FTIR showed more uniform PGS distribution in CA fibres. In vitro drug release tests indicated 400–600 µg of PGS is released from 11.9 mg fibre patches into 5mL PBS within 70 min, demonstrating effective drug penetration. Adding Polysorbate 80 (PS80) significantly increased PGS release. The Makoid‐Banakar model best suited EC fibres, while both the Makoid‐Banakar and Peppas Sahlin models fit CA fibres. These findings suggest that the fibrous patches offer a convenient, minimally invasive, and personalised method for delivering precise PGS doses in HRT. The study sets a strong foundation for further in vivo and cytotoxicity testing to validate the clinical effectiveness and safety of these patches in alleviating menopausal symptoms.

Item Type: Article
Uncontrolled Keywords: biomaterials, cellulose acetate, electrospinning, ethyl cellulose, menopause, polysorbate, polyvinylpyrrolidone, progesterone, transdermal
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
R Medicine > RG Gynecology and obstetrics
R Medicine > RS Pharmacy and materia medica
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 19 Mar 2026 15:57
URI: https://gala.gre.ac.uk/id/eprint/52677

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics